Moleculin Biotech News - MBRX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Moleculin Biotech Inc MBRX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.03 -2.63% 1.11 1.13 1.10 1.12 1.14 17:59:51
more quote information »

Recent News

Date Time Source Heading
10/22/201907:33EDGARCurrent Report Filing (8-k)
10/22/201907:30PRNUSMoleculin Increases Annamycin Production Due to Positive..
9/16/201907:00PRNUSMoleculin Announces its Sponsored Research at MD Anderson..
8/20/201907:30PRNUSMoleculin Announces CTRC Approval of WP1066 Pediatric Brain..
8/16/201917:35PRNUSMoleculin Biotech, Inc. Reports Financial Results for the..
8/16/201917:19EDGARCurrent Report Filing (8-k)
8/16/201917:17EDGARQuarterly Report (10-q)
8/14/201917:16EDGARNotification That Quarterly Report Will Be Submitted Late..
8/13/201907:34EDGARCurrent Report Filing (8-k)
8/13/201907:30PRNUSMoleculin Announces Completion of Lymphoma Trial Enrollment
8/06/201907:48EDGARCurrent Report Filing (8-k)
8/06/201907:30PRNUSMoleculin Announces Breakthrough Discovery: WP1066..
7/24/201907:31EDGARCurrent Report Filing (8-k)
7/24/201907:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/18/201916:02EDGARCurrent Report Filing (8-k)
7/18/201907:30PRNUSMoleculin Announces Annamycin in Acute Myeloid Leukemia in..
7/15/201916:26EDGARStatement of Changes in Beneficial Ownership (4)
7/15/201916:23EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
7/15/201916:22EDGARStatement of Changes in Beneficial Ownership (4)
7/15/201916:17EDGARStatement of Changes in Beneficial Ownership (4)
7/15/201916:14EDGARStatement of Changes in Beneficial Ownership (4)
7/15/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
7/15/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
7/12/201916:04EDGARCurrent Report Filing (8-k)
7/10/201907:30PRNUSMoleculin Files for New Patents for Annamycin After..
5/31/201916:09EDGARCurrent Report Filing (8-k)
5/24/201917:02EDGARStatement of Changes in Beneficial Ownership (4)
5/24/201917:02EDGARStatement of Changes in Beneficial Ownership (4)
5/24/201916:11EDGARCurrent Report Filing (8-k)
5/14/201907:32EDGARCurrent Report Filing (8-k)
5/14/201907:30PRNUSMoleculin Biotech, Inc. Reports Financial Results for the..
5/13/201916:04EDGARQuarterly Report (10-q)
5/07/201916:37EDGARCurrent Report Filing (8-k)
5/07/201907:30PRNUSMoleculin Announces Additional Positive Interim Results in..
5/03/201912:50EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/02/201911:48EDGARStatement of Ownership (sc 13g)
4/29/201916:12EDGARCurrent Report Filing (8-k)
4/29/201909:00PRNUSGenerex Biotechnology Announces Organizational Roadmap &..
4/29/201908:00PRNCAPositive Results From HMN Lithium Project P.E.A.
4/29/201907:00PRNUSUS Biopharma Company Undertakes Anti-Cancer Clinical Trials..
4/24/201906:03EDGARCurrent Report Filing (8-k)
4/24/201906:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/23/201913:31EDGARStatement of Ownership (sc 13g)
4/23/201908:40PRNUSMoleculin Announces $15.0 Million Registered Direct Offering
4/22/201907:30PRNUSMoleculin Announces Conference Call to Discuss Significant..
4/18/201907:30PRNUSMoleculin Receives FDA Approval of Fast Track Designation..
4/17/201907:30PRNUSMoleculin Announces Significant Discovery in Lung Cancer..
4/16/201916:13EDGARProxy Statement (definitive) (def 14a)
4/12/201916:06EDGARProxy Soliciting Materials (revised) (prer14a)
4/11/201916:12EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NASDAQ
MBRX
Moleculin ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.